IRRAS AB (publ) (IRRAS)の価格はいくらですか

IRRAS AB (publ) (IRRAS)の価格は$0.01791564です

IRRAS AB (publ) (IRRAS)の時価総額は何ですか

IRRAS AB (publ) (IRRAS)の時価総額は$20.30Mです

IRRAS AB (publ)（IRRAS）営業利益率

IRRAS AB (publ), a medical technology company established in 2011 and headquartered in Stockholm, Sweden, is dedicated to developing medical solutions that enhance the lives of critically ill patients globally. The firm specializes in neurocritical care products, aiming to transform patient outcomes and address complexities inherent in current treatment methods. Among its offerings is IRRAflow, an advanced irrigating intracranial drainage system that integrates controlled drainage, automated irrigation, and continuous intracranial pressure (ICP) monitoring, used effectively for treating hemorrhagic strokes and chronic subdural hematoma. Additionally, IRRAS provides the Hummingbird ICP monitoring system, comprising the HICP200 Control Module and various catheters like the H610 for quad ICP monitoring with drainage and the H110 for solo ICP monitoring. These Hummingbird neuromonitoring tools are vital for managing patients with elevated ICP caused by conditions such as traumatic brain injury, subarachnoid hemorrhage, and strokes. The company distributes its products to hospitals through both its direct sales force and a network of strategic distribution partners.

年	営業利益率	変化
提供された日付のデータは十分ではありません。

年

営業利益率

変化

提供された日付のデータは十分ではありません。

企業	営業利益率	営業利益率の差	国
Abbott Laboratories ABT.US	17.03%	-	US
Stryker Corporation SYK.US	22.03%	-	US
Medtronic plc MDT.US	17.86%	-	IE
Boston Scientific Corporation BSX.US	21.46%	-	US
Edwards Lifesciences Corporation EW.US	28.09%	-	US

企業

営業利益率

営業利益率の差

国